Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +1.59% | +18.15% | +67.53% |
27/05 | US, European nations consider vaccinating workers exposed to bird flu | RE |
24/05 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+44.98% | 4.07TCr | |
-10.87% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr | |
-8.12% | 1.12TCr |